Showing results (51-60 of 961) with videos related to

Sort By:
Pageof 97
Ejhaem|July 18, 2022
Acquired platelet dysfunction in newly diagnosed myelomaJoshua Mortimer, Nicola Gray, Michael Desborough, et al.
Ejhaem|July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myelomaCristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
Ejhaem|July 18, 2022
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder cloneKyoko Yoshihara, Yasuhito Nannya, Ikuo Matsuda, et al.
Ejhaem|July 18, 2022
Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathyAdam Khorasanchi, Amir M Ansari, Wendy Bottinor, et al.
Ejhaem|July 18, 2022
Mutational spectrum and prognosis in Chinese patients with prefibrotic primary myelofibrosisChi-Keung Cheng, Jennifer W Y Lai, Yuk-Lin Yung, et al.
Ejhaem|July 18, 2022
Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond-Blackfan anaemiaAkie Kobayashi, Ryusei Ohtaka, Tsutomu Toki, et al.
Ejhaem|July 18, 2022
Alcohol and tobacco use and risk of multiple myeloma: A case-control studySimon Cheah, Julie K Bassett, Fiona J Bruinsma, et al.
Ejhaem|July 18, 2022
Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approachToshiki Terao, Takafumi Tsushima, Daisuke Miura, et al.
Ejhaem|July 18, 2022
Bacillus Calmette-Guérin (BCG)-associated hemophagocytic lymphohistiocytosis in the setting of IFN-γR1 deficiency: A diagnostic dilemmaAnahita Razaghian, Leila Parvaneh, Mona Delkhah, et al.
Ejhaem|July 18, 2022
Etoposide-based treatment of adult HLH is associated with high biochemical response but poor survival outcomesMatthew C Nicholson, Leonie Naeije, Anna R Hayden, et al.
Pageof 97